The Securities and Exchange Commission is investigating Valeant Pharmaceuticals International Inc. (NYSE: VRX) in yet another probe. Shares of the beleaguered drug maker plummeted $14.85 to close at $65.80.
Another SEC probe into Valeant Pharmaceuticals
February 29, 2016 at 18:26 PM EST
